The effects of calcium phosphate deposition upon corrosion of CoCr alloys and the potential for implant failure
Source abstract
Abstract
Abstract Physical wear of orthopedic implants is inevitable. CoCr metal samples, typically used in joint reconstruction, corrode rapidly after removal of the protective oxide layer. The behavior of CoCr pellets immersed in human serum, fetal bovine serum (FBS), synovial fluid, and water were studied using time‐of‐flight secondary ion mass spectroscopy (ToF‐SIMS). The differences in the corrosive nature of human serum, FBS, synovial fluid, and water after 5 days immersion were highlighted by the oxide/hydroxide layer, which was, respectively, 25, 10, 1.5, and 3–3.5 nm thick. The thickness of calcium phosphate deposit from human serum, FBS, and synovial fluid was, respectively, 30, 20, and 2 nm. Co and Cr ions migrated from the bulk metal surface and were trapped in the serum deposits, where chromium existed as oxides, hydroxides, and phosphates, whereas the cobalt chemistry was dominated only by phosphates and hydroxides. This may account for the composition of wear debris from CoCr orthopedic implants, which are predominantly hydroxyphosphate compounds. From the literature, proteoglycans, pyrophosphates, phospholipids, lubricin, and superficial zone protein (SZP) have been identified as possible causes for the insignificant deposit of calcium phosphate from synovial fluid. Circulation of these compounds around the whole implant may inhibit calcium phosphate deposition and therefore contribute to osteolysis. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res, 2005
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Orthopaedic implants and arthroplasty · Titanium Alloys Microstructure and Properties · Orthopedic Infections and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. 10.2106/00004623-199274060-0000610.2106/00004623-199274060-00006 ↗
2. 10.1023/A:101613131002510.1023/A:1016131310025 ↗
3. 10.1302/0301-620X.76B5.808325510.1302/0301-620X.76B5.8083255 ↗
4. 10.2106/00004623-200004000-0000210.2106/00004623-200004000-00002 ↗
5. 10.2106/00004623-199608000-0001410.2106/00004623-199608000-00014 ↗
6. 10.1002/(SICI)1097-4636(199810)42:1<103::AID-JBM13>3.0.CO;2-M10.1002/(SICI)1097-4636(199810)42:1<103::AID-JBM13>3.0.CO;2-M ↗
7. 10.1023/A:102647372377710.1023/A:1026473723777 ↗
8. 10.1023/A:100890130264610.1023/A:1008901302646 ↗
9. 10.1002/jbm.a.1008810.1002/jbm.a.10088 ↗
10. 10.2106/00004623-199409000-0000910.2106/00004623-199409000-00009 ↗
11. 10.2106/00004623-199802000-0001510.2106/00004623-199802000-00015 ↗
12. Metal degradation products—A cause for concern in metal‐metal bearings?10.1097/01.blo.0000096810.78689.62 ↗
13. Local and distant products from modularity
14. SRIM 2003—The stopping and range of ion in matter (software).http://www.srim.org.
15. 10.1021/ac980696310.1021/ac9806963 ↗
16. 10.1021/ac990812h10.1021/ac990812h ↗
17. 10.1016/S0142-9612(03)00061-910.1016/S0142-9612(03)00061-9 ↗
18. 10.1002/jbm.82019060610.1002/jbm.820190606 ↗
19. 10.1002/jbm.a.3036810.1002/jbm.a.30368 ↗
20. 10.1016/0010-938X(95)00040-Q10.1016/0010-938X(95)00040-Q ↗
21. 10.1016/0013-4686(74)85012-710.1016/0013-4686(74)85012-7 ↗
22. 10.1149/1.156514210.1149/1.1565142 ↗
23. 10.1016/S0010-938X(03)00148-310.1016/S0010-938X(03)00148-3 ↗
24. 10.1016/0021-9797(86)90348-610.1016/0021-9797(86)90348-6 ↗
25. 10.2106/00004623-200004000-0000210.2106/00004623-200004000-00002 ↗
26. 10.1002/(SICI)1097-0029(19970215)36:4<313::AID-JEMT9>3.0.CO;2-M10.1002/(SICI)1097-0029(19970215)36:4<313::AID-JEMT9>3.0.CO;2-M ↗
27. 10.1023/A:102647372377710.1023/A:1026473723777 ↗
28. 10.1023/A:100890130264610.1023/A:1008901302646 ↗
29. 10.1002/jbm.a.1008810.1002/jbm.a.10088 ↗
30. 10.1023/A:102150562138810.1023/A:1021505621388 ↗
31. Berry CL · 198210.1007/978-3-642-68382-4 ↗
32. Hyaluronate in total hip‐replacement
33. 10.1016/j.biomaterials.2003.11.02310.1016/j.biomaterials.2003.11.023 ↗
34. 10.1016/S0736-0266(00)00040-110.1016/S0736-0266(00)00040-1 ↗
35. Surface‐active phospholipid in total hip arthroplasty
36. Synovial surfactant and the hydrophobic articular surface
37. 10.1097/00002281-200205000-0001610.1097/00002281-200205000-00016 ↗
38. 10.1186/ar14310.1186/ar143 ↗
39. Pyrophosphate, phosphate ion interaction—Effects on calcium pyrophosphate and calcium hydroxyapatite crystal‐formation in aqueous‐solutions
40. 10.1097/00002281-200405000-0001610.1097/00002281-200405000-00016 ↗
41. 10.1042/bj228046310.1042/bj2280463 ↗
42. 10.1016/S0142-9612(03)00618-510.1016/S0142-9612(03)00618-5 ↗
43. 10.1006/bbrc.2002.669910.1006/bbrc.2002.6699 ↗
44. 10.1097/00003086-199805000-0002810.1097/00003086-199805000-00028 ↗
45. 10.1097/01.blo.0000052938.71325.4610.1097/01.blo.0000052938.71325.46 ↗
46. 10.1097/00003086-199807000-0001010.1097/00003086-199807000-00010 ↗
47. 10.1097/01.blo.0000052938.71325.4610.1097/01.blo.0000052938.71325.46 ↗